6 min listen
Johnson & Johnson (JNJ) Earnings
FromSchwab Network
ratings:
Length:
7 minutes
Released:
Apr 20, 2021
Format:
Podcast episode
Description
David Toung says the FDA panel is not expected to approve the resumption of JNJ's vaccine this week. For the company, the vaccine issue may not be a material concern to the company's earnings and revenue Medical devices are expected to show robust growth due to elective procedures and consumer health products are expected to show improving sales.
Released:
Apr 20, 2021
Format:
Podcast episode
Titles in the series (100)
CEO of Super League Gaming, Ann Hand Discusses The State Of Esports During The Pandemic by Schwab Network